Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects (DOUFISPORT)

April 21, 2022 updated by: University Hospital, Brest

Fibromyalgia affects 1.4 now 2.2% of the general population whose symptom is the presence of widespread pain in all four quadrants of the body. Currently, there is no causal treatment of fibromyalgia syndrome.

The aim of this study is the evaluation of a specific training program on controls of pain in fibromyalgia patients by balancing the stress axis.

The primary endpoint is the improvement in the Visual Analogue Scale VAS difference) measured during the test of the thermode (difference between the average VAS measured between the 10th and 40th second of P1 and the average VAS measured between the 10th and 40th of the second P3) between D0 (3rd consultation) and M24 (5th consultation - end of study visit), which will be compared in the two groups..Salivary cortisol is also tested.

Study Overview

Detailed Description

A specific training program under the guidance of a physiotherapist, a professor of Adapted Physical Activity (APA) and individualized whose objective is to strengthen the parasympathetic tone and modulate the reactivity of the sympathetic system and the report of the Hypothalamic-Pituitary-Adrenal (HPA) axis.This training program consists of three sessions of 45 minutes of physical activity per week for 2 years. The exercise intensity is initially very low and will be gradually increased according to your abilities and your tolerance to stress. A 6-Minute Walk Test (6MWT) will be carried out by the physiotherapist and by Professor APA, every 6 months to monitor the progression. For tracking the training program, a phone call is scheduled every week during the first 3 months, then a phone call every 15 days during the following months until the end of the study.Evaluation of neuromodulation of pain will be measured thanks to thermodeTest , experimental method implementing a tonic thermal pain using a "Peltier type Thermode" 3 cm2 model TSA II and immersion in a bath of cold water.

Participants will be randomly assigned to 2 groups, "Training" group or "Control" group.

The control group is a training program supervised by physical therapists and teachers in Adapted Physical Activity, identical to the active program in its follow-up, but the intensity of the sessions is lower.

Study schedule :

  • 1st visit : screening visit at D-30
  • 2nd visit : inclusion at D-7
  • 3rd visit at D0
  • 4st visit between M6 and M9
  • 5th visit at M24

The patients included in the study will receive in addition to the training program, taking into bio-psycho-social multidisciplinary.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brest, France, 29200
        • CHRU Brest
      • Rennes, France, 35033
        • CHU Rennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Diagnosis of fibromyalgia is clearly established by the criteria of the American College of Rheumatology (ACR).
  • Body Mass Index (BMI) between 18.5 and 24.9 kg / m² (normal weight at HAS).
  • Spontaneous pain intensity greater than 3/10 on a VAS. Pain triggered by palpation must be equal to or greater than 4/10 of the EVA.
  • Patients with a medical certificate to the sport.

Exclusion Criteria:

  • Systemic disease, whether or not, generating pain musculoskeletal
  • Heart disease, respiratory, endocrine, metabolic or neurological.
  • Patients and patient pregnant lactating or planning to become pregnant within 2 years.
  • Patients who have changed in the last 2 months any pharmacological treatment.
  • Patients taking drugs that affect the heart rate variability
  • Patients who have conditions that could affect the cortisol levels
  • Patients with a psychiatric diagnosis of schizophrenia, delusional disorder and other personality disorders
  • Patients taking substances affecting cortisol secretion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: training group

The training program consists of three sessions of 45 minutes of physical activity per week for 2 years. During the first 6-9 months, two individual workouts, supervised by a physiotherapist and a session in Living.

Depending on the capacity and exercise tolerance of the patient, patients realize the second phase of training until 2 years of the study: three exercise sessions from 45 to 60 minutes per week of which group session led by a professor of Adapted Physical Activity (APA) and 2 autonomous sessions.

Thermal stimulation with test thermode Thermic stimulations (tonic heat pain stimulation and cold-pressor test) are used to test excitatory and inhibitory pain mechanisms

thermal stimulation with test thermode
Placebo Comparator: control group
A training program supervised by physical therapists and teachers in Adapted Physical Activity, identical to the active program in its follow-up, but the intensity of the sessions is lower than that of the training group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Pain as assessed by Visual analog scale
Time Frame: baseline to 24 months
baseline to 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
salivary cortisol
Time Frame: baseline to 24 months
three times : 3th visit at Day 0, 4th visit between month 6 and 9, 5th visit at month 24
baseline to 24 months
heart rate variability
Time Frame: baseline to 24 months
three times : 2th visit at Day -7, 4th visit between month 6 and 9, 5th visit at month 24
baseline to 24 months
Fibromyalgia Impact Questionnaire (FIQ)
Time Frame: baseline to 24 months
baseline to 24 months
Hospital Anxiety Depression Scale (HADS)
Time Frame: baseline to 24 months
baseline to 24 months
Pressure Pain Threshold (PSS)
Time Frame: baseline to 24 months
baseline to 24 months
International Physical Activity Questionnaire (IPAQ)
Time Frame: baseline to 24 months
baseline to 24 months
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: baseline to 24 months
baseline to 24 months
Saint-Antoine Pain Questionnaire (SAPQ)
Time Frame: baseline to 24 months
baseline to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gildas L'HEVEDER, Doctor, CHRU Brest

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2015

Primary Completion (Actual)

February 21, 2019

Study Completion (Actual)

October 21, 2021

Study Registration Dates

First Submitted

February 26, 2015

First Submitted That Met QC Criteria

June 30, 2015

First Posted (Estimate)

July 1, 2015

Study Record Updates

Last Update Posted (Actual)

April 22, 2022

Last Update Submitted That Met QC Criteria

April 21, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Physical activity

3
Subscribe